专利检索 ap:("Wyeth") AND inv:"BARRIOS SOSA, Ana, Carolina" 第 1 页

1.

发明公开
THIENO[2,3-B]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：噻吩[2,3-B]吡啶-5-羧酸盐蛋白酶蛋白酶

公开(公告)号：EP1937690A1

公开(公告)日：2008-07-02

申请号：EP06804164.9

申请日：2006-09-27

申请人： Wyeth

发明人： BOSCHELLI, Diane, Harris , COLE, Derek, Cecil , ASSELIN, Magda , BARRIOS SOSA, Ana, Carolina , WU, Biqi , TUMEY, Lawrence, Nathan

IPC分类号： C07D495/04 , A61K31/4365 , A61P37/06

CPC分类号： C07D495/04

摘要： Disclosed are compounds of Formula I: Formula (I); wherein R1, R2, R3, R4 , and X, are defined hereinbefore in the specification, which can be useful in the treatment of autoimmune and inflammatory diseases, and processes for producing said compounds.

2.

发明公开
THIENO[3,2-B]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-B]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：噻吩并[3,2-b]吡啶-6-甲腈和噻吩并[2,3-b]吡啶-5-腈作为蛋白激酶抑制剂

公开(公告)号：EP1565474A2

公开(公告)日：2005-08-24

申请号：EP03783385.2

申请日：2003-11-14

申请人： Wyeth

发明人： BOSCHELLI, Diane, Harris , ZHANG, Nan , BARRIOS SOSA, Ana, Carolina , DURUTLIC, Haris , WU, Biqi

IPC分类号： C07D495/04 , A61K31/4365 , A61P35/00 , A61P9/10 , A61P19/10 , A61P13/12

CPC分类号： C07D495/04

摘要： This invention provides compounds of Formula (1 a) - (1f) wherein:X, R1, and R2 are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.

3.

发明公开
THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AS PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：噻吩并[3,2-B]吡啶-6碳二亚氨基葡糖苷酶

公开(公告)号：EP1756117A2

公开(公告)日：2007-02-28

申请号：EP05742281.8

申请日：2005-05-10

申请人： Wyeth

发明人： BOSCHELLI, Diane, Harris , ZHANG, Nan , BARRIOS SOSA, Ana, Carolina , DURUTLIC, Haris , WU, Biqi

IPC分类号： C07D495/04

CPC分类号： C07D495/04 , A61K31/44 , A61K31/497 , A61K31/535

摘要： This invention provides compounds of Formula II: wherein: R1, R2 and X are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, myocardial infarction, neuropathic pain, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection. The invention also provides processes for producing said compounds.